Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcoma

E-ISSN： 1545-5017|65|4|pbc.26896-pbc.26896

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.65, Iss.4, 2018-04, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602

By Sato Yozo

Upsala Journal of Medical Sciences, Vol. 118, Iss. 1, 2013-03 ,pp. : 16-22

Informa Healthcare

Access to resources Recommend Favorite

Early response to arterial chemotherapy

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 726-732

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 5, 2015-11 ,pp. : 1407-1420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor heterogeneity in esophageal cancer

DISEASES OF THE ESOPHAGUS (ELECTRONIC), Vol. 28, Iss. 2, 2015-02 ,pp. : 172-179

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity

Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. : 107-117

Karger

Access to resources Recommend Favorite